Post Market Study for VasQ, an External Support Implant for Arteriovenous Fistula
Public ClinicalTrials.gov record NCT06516653. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Postmarket Surveillance, Prospective, Multicenter, Randomized, Controlled Study Evaluating the Performance of VasQ for Its Intended Use.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
VasQ is an external support implant for arteriovenous fistulas created for dialysis access. This is a postmarket surveillance, prospective, multi-center, randomized, controlled, open label trial enrolling 300 patients randomized into two study arms: * Treatment arm: End to side fistula supported with VasQ * Control: Standard of care end to side fistula
Study identification
- NCT ID
- NCT06516653
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- 300 participants
Conditions and interventions
Conditions
Interventions
- Arteriovenous fistula creation for dialysis vascular access Procedure
- VasQ Device
Procedure · Device
Eligibility (public fields only)
- Age range
- 18 Years to 80 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 12, 2025
- Primary completion
- Jul 31, 2027
- Completion
- Apr 30, 2028
- Last update posted
- Jul 13, 2026
2025 – 2028
United States locations
- U.S. sites
- 9
- U.S. states
- 9
- U.S. cities
- 9
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Fresenius Vascular Care Long Beach | Long Beach | California | 90706 | Recruiting |
| Sarasota Memorial Hospital | Sarasota | Florida | 34239 | Recruiting |
| Grady Memorial Hospital | Atlanta | Georgia | 30303 | Recruiting |
| Brigham and Women's Hospital | Boston | Massachusetts | 02115 | Recruiting |
| Greenwood Leflore Hospital | Greenwood | Mississippi | 38930 | Recruiting |
| Azura Surgery Center Las Vegas | Las Vegas | Nevada | 99128 | Active, not recruiting |
| Fresenius Vascular Care Columbia | Columbia | South Carolina | 29203 | Recruiting |
| Houston Methodist Hospital | Houston | Texas | 77030 | Recruiting |
| Fairlawn Surgery Center | Roanoke | Virginia | 24014 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Recently updated End Stage Renal Disease trials
Other public records listing End Stage Renal Disease. Sorted by last update posted; newest first. Not a recommendation.
- NCT04163614: Blood Pressure Slopes and Ultrafiltration in Hemodialysis Patients Recruiting
- NCT07696962: Study of ChoironeX GalKO Porcine Thymokidney Xenotransplantation in End-Stage Renal Disease Not yet recruiting
- NCT04392206: AMSC for Reducing Anastomotic Stenosis in Primary Arteriovenous Anastomoses Recruiting
- NCT03674307: Screening for Asymptomatic Coronary Artery Disease in Kidney Transplant Candidates Active, not recruiting
- NCT06422871: PReSeRVE-HD: Observational Study of the Merit HeRO® Graft and Super HeRO® in Patients on Hemodialysis Recruiting
- NCT06182475: Development and Test of a Communication Skills Training for Transplant Providers - Aims 2 & 3 Not yet recruiting
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06516653, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 13, 2026 · Synced Jul 30, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT06516653 live on ClinicalTrials.gov.